caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1932242062

Jelena KaoMD

PRACTICECALIFORNIA CANCER CARE A MEDICAL GROUP INCSee all providers at this practice →
Medical OncologySan Mateo, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Jelena Kao's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Karen Chee
Medical Oncology · San Mateo, CA
37127
Kent Adler
Medical Oncology · San Mateo, CA
30132
Jon Keller
Pathology · Palo Alto, CA
24229
Avanti Ambekar
Diagnostic Radiology · San Mateo, CA
2177
Clay Napper
Diagnostic Radiology · San Mateo, CA
2068
Harriet Borofsky
Diagnostic Radiology · San Mateo, CA
1736
Jane Woo
General Surgery · Stockbridge, GA
1642
Gregory Lim
Diagnostic Radiology · Burlingame, CA
1693
Jeffrey Guttas
Cardiology · San Mateo, CA
1555
DUNCAN, KEITH1354
Charles Everett
Pulmonary Disease · Burlingame, CA
1242
NPI 12654935061243
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$55
Payment records
2
By payment type
Food and Beverage$55
PRESCRIBING · PART D · 2024
Total Rx claims
191
Beneficiaries
—
Total drug cost
$36K
Distinct drugs
4
Brand share
15.7%
Top prescribed drugs
Anastrozole60 claims
Hydroxyurea58 claims
Letrozole43 claims
Apixaban30 claims
QUALITY · MIPS · 2024
Final MIPS score
87.0
Quality
86.8
Cost
70.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.51%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
76
Unique beneficiaries
—
Total services
78
Distinct HCPCS
2
Medicare payment
$6K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 268 Medical Oncology providers in CA — above median (cohort median 1,130).